Tilray Brands, Inc. (NASDAQ:TLRY – Get Free Report)’s share price dropped 4.3% during trading on Wednesday. The stock traded as low as $2.23 and last traded at $2.25. 4,999,361 shares changed hands during trading, an increase of 17% from the average daily volume of 4,283,394 shares. The stock had previously closed at $2.35.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on the company. TD decreased their target price on Tilray Brands from $4.70 to $4.50 and set a “buy” rating for the company in a research report on Monday, October 5th. Zacks Research downgraded shares of Tilray Brands from a “hold” rating to a “strong sell” rating in a research report on Tuesday, September 29th. Canaccord Genuity Group decreased their target price on shares of Tilray Brands from $4.50 to $4.00 and set a “hold” rating for the company in a research note on Friday, October 9th. Weiss Ratings lowered shares of Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, October 23rd. Finally, TD Securities raised Tilray Brands to a “strong-buy” rating in a report on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Tilray Brands has an average rating of “Hold” and an average price target of $5.90.
Check Out Our Latest Stock Report on Tilray Brands
Tilray Brands Trading Down 8.7%
The stock has a fifty day moving average of $3.20 and a 200 day moving average of $5.05. The company has a market capitalization of $279.32 million, a P/E ratio of -1.35 and a beta of 2.04. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.11 and a current ratio of 1.88.
Tilray Brands (NASDAQ:TLRY – Get Free Report) last issued its quarterly earnings results on Thursday, October 8th. The company reported ($0.02) EPS for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.16. Tilray Brands had a negative return on equity of 10.39% and a negative net margin of 16.91%. The business had revenue of $257.15 million during the quarter, compared to analysts’ expectations of $266.26 million. As a group, equities research analysts anticipate that Tilray Brands, Inc. will post -0.52 EPS for the current fiscal year.
Institutional Trading of Tilray Brands
A number of hedge funds and other institutional investors have recently modified their holdings of the company. BlackRock Inc. bought a new position in Tilray Brands in the 2nd quarter worth $2,073,000. Goldman Sachs Group Inc. raised its stake in Tilray Brands by 68.5% during the 3rd quarter. Goldman Sachs Group Inc. now owns 350,843 shares of the company’s stock valued at $1,316,000 after purchasing an additional 142,569 shares during the period. Swiss National Bank lifted its holdings in Tilray Brands by 4.1% in the 1st quarter. Swiss National Bank now owns 230,503 shares of the company’s stock worth $1,491,000 after purchasing an additional 9,100 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Tilray Brands by 6.1% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 208,229 shares of the company’s stock worth $935,000 after purchasing an additional 11,894 shares during the period. Finally, Cetera Investment Advisers boosted its stake in Tilray Brands by 37.5% in the 3rd quarter. Cetera Investment Advisers now owns 129,123 shares of the company’s stock worth $484,000 after purchasing an additional 35,228 shares during the period. 9.35% of the stock is owned by hedge funds and other institutional investors.
About Tilray Brands
Tilray Brands is a global cannabis and consumer packaged goods company. Its cannabis business produces and sells medical and adult-use products, including dried flower, oils, extracts and edibles, under brands such as Good Supply, Solei, Redecan and Broken Coast. The company serves customers in Canada, the United States and international markets. Its activities include medical cannabis distribution in countries where permitted, as well as cannabis and hemp-related products in North America, subject to local regulations.
Recommended Stories
- Five stocks we like better than Tilray Brands
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.
